
🇪🇨 CCM Fellow @BCMHouston | Former IM Chief Resident @TigmerSA_IntMed and researcher @UTMDAnderson & @ONCCCRNET
Houston, Texas
Joined May 2019
- Tweets500
- Following630
- Followers713
- Likes2.2K
Pinned Tweet
Incredibly humbled to match into Critical Care Medicine at @bcmhouston
A dream since medical school, shaped by my family and mentors who believed in me.
Grateful for every step of this journey. Ready for what comes next.
#Match2025 @TheNRMP @SCCM @accpchest
The International Symposium of Critical Care in Cancer Patients returns to @MDAndersonNews, Nov 4–6.
🔹 Oncologic critical care
🔹 POCUS workshop
🔹 In-person + virtual
A great opportunity to learn and connect.
🔗 mdanderson.cloud-cme.com/cou…
@ONCCCRNET #OncCrit #CriticalCare
Internal Medicine Residency ✅ @TigmerSA_IntMed
Grateful, humbled, and honored to close this chapter. Thankful for my family, friends, mentors, faculty, co-residents, and the patients who shaped me along the way.
Excited for the next step: CCM at @bcmhouston.
John A. Cuenca, MD retweeted
The "current standard of care for septic shock" just published in ICM is an evidence based update. Current optimal management for septic shock involves prompt recognition, judicious use of fluids & vasoactive drugs, early appropriate antibiotic use, regular reassessment & more..
John A. Cuenca, MD retweeted
Presented at CCR Down Under 2025:
In a randomized trial involving critically ill patients undergoing intubation in EDs or ICUs, the use of ketamine for the induction of anesthesia did not lead to significantly lower in-hospital mortality than etomidate. Full trial results: nej.md/44EOlxB
@CritCareReviews
John A. Cuenca, MD retweeted
Positive communication in ICU reduces burnout and enhances workplace culture among staff. Read the HELLO trial, just published in ICM jpn01.safelinks.protection.o… @ElieAzoulay5
John A. Cuenca, MD retweeted
Original Article: A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia nej.md/47glh02
Editorial: Glucocorticoids for Pneumonia in Africa — Old Therapy, New Context nej.md/4qgjdxH
#LIVES2025
John A. Cuenca, MD retweeted
The Sequential Organ Failure Assessment (SOFA) score is the most widely used tool for evaluating organ dysfunction.
This week, JAMA published the SOFA-2 score, a data-driven update that incorporates current organ support therapies and introduces new scoring thresholds. ja.ma/47dp0wG
John A. Cuenca, MD retweeted
(1/x) Andromeda-Shock 2 was just published in JAMA and is the most important septic shock trial in the past DECADE.
They found that phenotyped resuscitation improves the composite outcome of mortality, vital support, and hospital LOS.
Here's how you can apply this protocol to your practice 👇
John A. Cuenca, MD retweeted
🚨Our new paper is out today in Nature! We show that SARS-CoV-2 mRNA vaccines can sensitize tumors to immune checkpoint blockade (ICI) — revealing that clinically available RNA vaccines may act as potent immune modulators. nature.com/articles/s41586-0…
John A. Cuenca, MD retweeted
Nature research paper: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade
go.nature.com/4o8ydwh
Very happy to reconnect with many friends and mentors. #CHEST2025 @accpchest
Had a great time at #CHEST2025, tons of learning, inspiration, and fun! Grateful to @accpchest for an amazing meeting, and proud to represent @TigmerSA_IntMed with 3 posters this year.
What a privilege to have @Askins_Razor from @CritCareTime present a fantastic talk for @TigmerSA_IntMed Grand Rounds! #MedEd #MedTwitter
John A. Cuenca, MD retweeted
🚨Join us for the 3rd Virtual World Symposium of Oncologic Critical Care 🌏
Cutting-edge Science, Global collaboration, Expert insights on cancer & critical illness.
📆July 17-18! 🖥️ Virtual
🔗 REGISTER NOW: wsoccvirtual.com/
🎤 Honored to speak at the Third World Symposium of Oncologic Critical Care hosted by @MDAndersonNews & @ONCCCRNET
I’ll be presenting (in Spanish 🇪🇸) on immune checkpoint inhibitor-related respiratory failure, a growing challenge in #OncCrit.
#PCCM #Sepsis #Immunotherapy
That awesome moment when your mentee cites your work on her research. Proud of @paoyepezg growth and strong work in the oncologic critical care field. #ATS2025
Grateful for the opportunity to present 2 cases at #ATS2025—both cancer patients with resp failure and bilateral infiltrates:
❗️PJP and rhino-orbital mucormycosis
❗️Antibody-drug conjugate pneumonitis
Similar presentation, divergent etiologies.
Much research still needed🔬
We invite you to read our latest publication in @intensiva_med 📢
In this systematic review of septic shock RCTs, we found striking variability in how mortality timeframes are reported—making cross-trial comparisons challenging.
🔗 medintensiva.org/en-mortalit…
#Sepsis #MedTwitter











































